4-aminoquinazoline has been researched along with bibw 2992 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnhof, H; Bader, G; Böttcher, J; Ettmayer, P; Gerstberger, T; Gmachl, M; Haering, D; Hauer, K; Hela, W; Hofmann, MH; Kennedy, MD; Kessler, D; Kofink, C; Kraut, N; Lamarre, L; McConnell, DB; Mendes, RL; Meyer, R; Munico-Martinez, S; O'Connell, JC; Pototschnig, N; Ramharter, J; Richard, D; Rumpel, K; Salamon, C; Sanderson, M; Schnitzer, R; Weiner, I; Werni, P; Wolkerstorfer, B; Wunberg, T; Zöphel, A | 1 |
1 other study(ies) available for 4-aminoquinazoline and bibw 2992
| Article | Year |
|---|---|
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS.
Topics: Afatinib; Allosteric Regulation; Binding Sites; Catalytic Domain; Colorectal Neoplasms; ErbB Receptors; Humans; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Protein Interaction Maps; Proto-Oncogene Proteins p21(ras); Quinazolines; SOS1 Protein | 2021 |